Key points are not available for this paper at this time.
Pediatric formulation development is a critical area of pharmaceutical research aimed at creating safe, effective, and acceptable medications for children. This field faces unique challenges due to the physiological and developmental differences between children and adults. The gastric pH, metabolic rates, and organ functions in children vary significantly from adults, necessitating specialized approaches to drug formulation. Dosage form selection is a key consideration, with liquid formulations often preferred for younger children and solid forms for older ones. Taste masking remains a crucial aspect, as palatability directly impacts medication adherence in pediatric patients. Regulatory bodies have established guidelines to ensure the safety and efficacy of pediatric formulations, offering incentives to encourage research in this area. Recent advancements include the application of nanotechnology to enhance drug delivery and bioavailability, and the emergence of personalized medicine approaches tailored to individual genetic profiles. Novel drug delivery systems, such as controlled-release formulations, are improving the management of chronic conditions in children. However, challenges persist, including limited clinical trial data and the need for age-appropriate dosage forms. Future research should focus on developing innovative taste-masking technologies, creating more robust and versatile dosage forms, and integrating advances in biotechnology. Collaboration among pharmaceutical companies, regulatory agencies, and healthcare professionals is essential to address the evolving needs of pediatric patients and improve overall healthcare outcomes in this vulnerable population
S et al. (Fri,) studied this question.